Activities

IDEAL4OMOP Research Leadership Training 2024

A FUNDED TRAINING COURSE TO EQUIP THE REAL-WORLD EVIDENCE RESEARCH LEADERS OF THE FUTURE

Outcomes research has never been more important in cancer care. European Cancer Mission priorities (and funding) now reflect the key role that real-world evidence (RWE; efficient and scalable evidence generation from routine electronic medical records) has in highlighting and driving changes in clinical practice. Standardisation of source data, through translation to an accessible common data model, is central to that efficiency.

The Digital Institute for Cancer Outcomes Research (DIGICORE) is committed to driving this standardisation across Europe. Supported by a substantial Interregional Innovation Investment (I3) grant from the European Regional Development Fund (ERDF), DIGICORE is building a research network of 20 centres (80,000 new cancer diagnoses per year), deploying technology that includes translation of medical records to Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) standards for cancer.

But there is a critical skills gap - few clinical researchers have the skills to scale digital methods into care systems, skills that will enable the international transformation of care quality. The IQVIA-DIGICORE Early-career Leadership Programme for OMOP (IDEAL4OMOP) is designed to address this gap, equipping young research leaders with the skills they will need to drive future international RWE, including accessing appropriate funding to sustain the effort.

The IDEAL4OMOP training programme has been funded by the DigiONE I3 programme, with additional study funding donated by IQVIA.

IDEAL4OMOP in numbers

IDEAL4OMOP training programme combines

overview

An overview of the opportunities, challenges and practice of RWE in cancer

ohdsi

An overview of OHDSI cancer OMOP, including opportunities and limitations

technical

Technical skills to plan and implement OMOP studies, including novel study designs and technologies, protocol development and delivery of a proof-of-concept study

research

Research leadership skills, including self-awareness, forming teams across diverse functions and geographies, influencing systems and managing projects and budgets

IDEAL4OMOP is based on years of academic and commercial outcomes research, building on internal DIGICORE pilot schemes.

The programme introduces the technical skills required to develop a cancer OMOP study protocol, a competitive RWE research proposal and to set up a multinational collaboration guided by an experienced Leadership Advisory Board.

aim
Aim

To equip European researchers with the necessary skills and experience in real-world outcomes research to lead academic and commercial multi-centre funding bids.

outcome
Outcome

Comprehensive RWE skills that can be applied to existing cancer data in your institution; a new peer network across European cancer institutions; an EMR-driven academic research protocol using cancer OMOP; completed RWE analysis and clinical conference poster.

delivery
Delivery

20 months part-time training (to December 2025) in technical RWE and research leadership skills, including the facilitation of multi-country pilot project collaborations and competitive funding for simple protocol delivery.

benefits
Benefits

Building new skills in OMOP and research leadership; developing an international network of like-minded cancer researchers; access to funding to develop and deliver an international research protocol (subject to funding award).

digital
Pragmatic Digital Trials

Applicants will be already involved in research, employed by an oncology healthcare provider or not-for-profit, and <45 years old. Eligible backgrounds include: clinical, pathology, data science, research management. All course costs are covered but applicants will need senior support, in terms of agreed study time and backfill (where required).

For information about the Programme please contact info@digicore-cancer.eu

Estimated Time Commitment

Timeline

Learn more about IDEAL4OMOP from our trainees

Study fund award

Congratulations to all teams for submitting study proposals to the Leadership Advisory Board in September 2024. The LAB was pleased to award >€100,000 study funding to the team working in colorectal cancer, who will now be working to deliver their findings in 2025.
Their winning presentation is attached here.